Reading time: 5 minutes Kate Secombe The treatment for many blood cancers can be invasive and have a range of side effects. One such side-effect is known as Graft versus Host Disease (GvHD). While GvHD invokes a range of unwanted symptoms, we currently do not fully understand how and why it develops. New research by... Continue Reading →
Building a Highway to Tumors
Sara Musetti Estimated reading time: 5 minutes It seems talking about the immune system and how it can fight cancer is all the rage these days, especially here at OncoBites. But talking about it can be tricky, especially because most people seldom think about their immune system. It’s a part of your body, but… which... Continue Reading →
Risk of Infection in Cancer Patients: Life in the Time of Coronavirus
Reading time: 3 minutes Manisit Das It is a scary and anxious moment for many of us, and if you are on the internet, it is hard to miss updates about the latest coronavirus disease, COVID-19. The viral disease is characterized by flu-like symptoms and may cause respiratory infections in certain individuals, was declared a... Continue Reading →
Pembrolizumab – the miraculous drug
Reading time: 5 minutes Varshit Dusad A cancer diagnosis is generally perceived to be a death sentence. With millions of people dying of cancer every year, this does not seem to be at all outrageous. However, researchers all over the world, in academia and industry alike, have been relentlessly pursuing novel therapies and drugs to... Continue Reading →
Overcoming the Limitations of CAR-T Therapy: Cytokine Storm
Reading time: 3 minutes Alex S. Woodell A warm breeze whips by as you notice a peculiar set of clouds forming in the distance. These cumulus clouds are tall with bumpy protrusions that flatten out near the top to form a silhouette of a giant anvil. As condensation builds in these behemoths, the bright sunlight... Continue Reading →
Players in Cancer Metastasis: Part Two
Reading time: 4 minutes Shaye Hagler For those of you whose lives have been impacted by cancer, you might have heard of the term “metastasis.” We call cancer metastatic when it breaks off from the initial tumor and travels to other organs. You might also have heard it being referred to before as “stage 4... Continue Reading →
Too Much Potassium Might Be Poisoning Your Anti-Tumor Immunity
Reading time: 4 minutes Sara Musetti Cancer immunotherapy has been a very hot topic here at OncoBites (because it’s a hot topic right now among cancer researchers too), but let me be super clear ⎯ it is COMPLICATED. Your immune system is balanced extremely delicately to avoid sending you into shock each time you are... Continue Reading →
Can exercise prevent cancer recurrence?
Reading time: 3 minutes Bekah Schulz It is well accepted that exercise is beneficial for human health and boosts overall energy level. However, the questions remains: can exercise be used as a cancer therapy? Research is indicating that it can. Over the past 20 years, studies have demonstrated that exercise decreases the risk of recurrence... Continue Reading →
Overcoming the Limitations of CAR-T Therapy: Burnout
Reading time: 4 minutes Alex S. Woodell Marathon runners are an interesting breed. In order to complete the grueling 26.2 mile circuit, they must push their mental and physical boundaries to the limit. Seasoned runners possess great strength, focus, resilience, and determination. Each of these qualities is a testament to the intense training schedules they... Continue Reading →
Sneaking into the non-conventional niches: Using gamma delta T cells to fight cancer
Reading time: 6 minutes Payal Yokota Despite the advent and access to a variety of targeted immunotherapy approaches, the current paradigm for solid tumors still remains if you can cut it out – you do! Depending on the grade of tumor and degree of metastasis, there’s a substantial risk of tumor resurgence. In those cases,... Continue Reading →
Patterns in combat: Using old cues in the battle against cancer
Reading time: 5 minutes Manisit Das As humans, we are naturally programmed to recognize patterns. They help us detect cues in our surroundings and aid our decision making. We associate camouflage patterns with battle dress, assortments of red and green with the holidays; these recognition events help us to put things in boxes in our... Continue Reading →
Bacteria in Cancer therapy: Friend or Foe?
Reading time: 5 minutes Varshit Dusad Bacteria are our unallied neighbors, which depending upon circumstances chooses to be our friend or foe. While bacteria such as E.coli have often been the workhorses for molecular biology studies, they have other uses as well. Surprisingly, they have enormous potential for cancer therapy. No, I am not talking... Continue Reading →
Cancer and Vascular Permeability
Reading time: 5 minutes Yitong Li One of the biggest hurdles that stall new developments in cancer therapy is how to effectively deliver the treatment to the tumor. Most commonly, pharmaceutical agents and immunotherapies make their way to the tumor via the bloodstream. Hence, the successful emigration of these agents out of the blood vessels... Continue Reading →
Predicting the future: when cancer drugs only work for some patients
Reading time: 5 minutes Shaye Hagler The discovery of accelerators and brakes in our immune system in the early 1990s was fundamental to designing the cancer immunotherapy platforms we use today, which is why it won the 2018 Nobel Prize in Medicine or Physiology. Now, immune checkpoint inhibitors like anti-PD-1 can work in tandem with... Continue Reading →
Are humans immune to CRISPR/Cas9 gene editing?
Reading time: 4 minutes Morgan McSweeney CRISPR-Cas9 is the molecular gene editing system that has inspired hopes for a solution to genetic disease. By studying how bacteria use the CRISPR-Cas system to defend themselves against bacteriophages (viruses that infect bacteria), scientists have developed methods to use those same molecular scissors to cut out human genes... Continue Reading →
When good cells go bad: White blood cells may aid in tumor recurrence
Reading time: 4 mins Sara Musetti “I lit up like a Christmas tree, Hazel Grace.” This line, from John Green’s bestselling novel The Fault in Our Stars, hits hard. A young teenage survivor of cancer has had a widespread relapse picked up in one of his many routine scans since going into remission years earlier.... Continue Reading →
A CAR-T therapy without the T-cells
Varshit Dusad Imagine a dystopian world. Here, some citizens of an otherwise well-functioning state have gone rogue and are running an anti-national agenda. They are always plundering the natural resources meant to be evenly distributed among the population. They are quite cunning as they start slowly by deviating from the laws of their natural order... Continue Reading →
Vaccines as Cancer Prevention and Therapies
Rachel Cherney Cancer is a complex set of diseases, characterized by uncontrolled growth and metastasis, destroying important organs and bodily systems. It can occur in almost any part of the body, and in most cases, it is impossible to determine how or when it will develop, certain genetically linked cancers perhaps being an exception. Because... Continue Reading →
Cancer Immunotherapy wins the 2018 Nobel Prize
Sara Musetti and Manisit Das Early October is an exciting time of the year when people all over the world turn their eyes to Stockholm to see the winners of the Nobel Prize. Yesterday, James Allison and Tasuku Honjo jointly won the 2018 Nobel Prize in Medicine or Physiology for their work discovering the function... Continue Reading →
Dealing With The Pitfalls of Checkpoint Security
Jason Tetro If you’ve ever traveled internationally, you know you need a passport. This document is your access pass to the world. What you might not know is that this rather plain looking document is filled with a variety of different checkpoints to ensure authenticity. Some passports have biometric chips, others have incorporated images only... Continue Reading →
Oncology’s White Whale: Crossing the Blood-Brain Barrier
Sara Musetti When someone says the word “cancer.” it can tie knots in the guts of even the strongest among us. There is no pretending that cancer isn’t a terrifying phenomenon that has touched most of our lives. Very few cancers, however, are able to elicit the chill that brain cancer does, in patients, family... Continue Reading →
Helping Our Body’s Killers Kill off Cancer, Naturally
Nisitha Sengottuvel At OncoBites, we’ve talked about many facets of cancer, the many internal and external factors that can affect tumor growth, and the established and developing methods to detect and treat cancer. We’ve also begun to cover the many ways in which biomedical science falls short in effectively treating cancer. Being diagnosed with cancer... Continue Reading →
Can mental state affect tumor growth? The link between psychology, immunology, and oncology
Shaye Hagler At Oncobites, we’ve been talking a lot about the role of immunity in cancer. Understanding the immune system is vital to understanding both what drives cancer and what protects us against it. One of the biggest paradoxes in cancer research is that immune system activation is important in fighting cancer via a process... Continue Reading →
Feeling the ‘heat’ from neighbors: Microenvironment driving cancers in the gut
Manisit Das Not long ago Tamara mentioned in her OncoBites article that it is often hard to determine what factors drive cancer. Even after a mutation responsible for fueling cancer growth is identified, we do not always know how that mutation contributes to tumor formation. Understanding these mechanisms is however quite important. As we gain... Continue Reading →
Immune cells work together to enable successful cancer therapy
Morgan McSweeney A group of researchers from the University of California - San Francisco recently found that the presence of a certain group of immune cells in tumors (“stimulatory dendritic cells,” or SDCs) can predict better cancer outcomes, at least in melanoma patients. For example, in patients treated with checkpoint inhibitors (drugs that work by... Continue Reading →
Stumbling before the beast: Not all cancer clinical trials end in drug approval
Manisit Das Since the beginning of OncoBites, we’ve talked a lot about immunotherapy: using our own immune cells to destroy the cancer cells? We can’t get enough of it! In one post, we highlighted a revolutionary approach recently approved by the US Food and Drug Administration (FDA) using genetically modified immune cells to fight cancer,... Continue Reading →
Bone found to abet Lung Cancer
Natasha Vinod Rudolph Virchow was one of the first physicians to study diseases from the standpoint of cells. He applied his cell theory “Omnis cellula e cellula” ("every cell originates from another cell") to the study of cancer and reasoned that cancer results from the failure of the regulatory mechanism of the cells to control... Continue Reading →
Cancer: a many headed beast
Emily B. Harrison, Ph.D. Every year more than one million women are diagnosed with breast cancer. Tumors are most often discovered through screening techniques like self-checks, breast exams, or mammograms. Immediately, plans are made to extract the tumor either by removing a small area around the tumor, a lumpectomy, or the entire breast in a... Continue Reading →
The Immune Landscape of Cancer
Morgan McSweeney Cancer is not a single disease. It is a broad term that describes a number of related conditions in which cells’ growth has begun to bypass the usual checks and balances. To study the spectrum of cancers, the National Institutes of Health have established The Cancer Genome Atlas (TCGA), a collaborative project aimed... Continue Reading →
Immunotherapy in Pancreatic Cancer: Does Bacteria hold the answer?
Manisit Das Your gut is crawling with bacteria, despite your devoted hygiene practices. Disgusting for your sophisticated self, isn’t it? Surprising as it is, over the course of evolution our bodies tolerated the microbial communities in our body, even cherished them. Hundreds of thousands of bacteria and other microorganisms call us home and play a... Continue Reading →